These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 38177232)
1. A latent profile analysis of tear cytokines and their association with severity of dry eye disease in the Dry Eye Assessment and Management (DREAM) study. Chen Y; Mallem K; Asbell PA; Ying GS Sci Rep; 2024 Jan; 14(1):526. PubMed ID: 38177232 [TBL] [Abstract][Full Text] [Related]
2. Association of Tear Cytokine Ratios with Symptoms and Signs of Dry Eye Disease: Biomarker Data from the Dry Eye Assessment and Management Study. Zhao CS; Chen Y; Ying GS; Asbell PA; Curr Eye Res; 2024 Jan; 49(1):16-24. PubMed ID: 37781912 [TBL] [Abstract][Full Text] [Related]
3. Association of Tear Cytokine Concentrations with Symptoms and Signs of Dry Eye Disease: Baseline Data from the Dry Eye Assessment and Management (DREAM) Study. Roy NS; Wei Y; Ying GS; Maguire MG; Asbell PA; Curr Eye Res; 2023 Apr; 48(4):339-347. PubMed ID: 36632643 [TBL] [Abstract][Full Text] [Related]
4. Association between systemic medication use and severity of dry eye signs and symptoms in the DRy eye assessment and management (DREAM) study. Guo M; Diaz GM; Yu Y; Patel CA; Farrar JT; Asbell PA; Ying GS; Ocul Surf; 2024 Apr; 32():112-119. PubMed ID: 38307463 [TBL] [Abstract][Full Text] [Related]
5. Age Associations with Dry Eye Clinical Signs and Symptoms in the Dry Eye Assessment and Management (DREAM) Study. Zhao M; Yu Y; Ying GS; Asbell PA; Bunya VY; Ophthalmol Sci; 2023 Jun; 3(2):100270. PubMed ID: 36846104 [TBL] [Abstract][Full Text] [Related]
6. Sex-related differences and hormonal effects in the Dry Eye Assessment and Management (DREAM) study. Zhao M; Yu Y; Roy NS; Ying GS; Asbell P; Bunya VY Br J Ophthalmol; 2023 Dec; 108(1):23-29. PubMed ID: 36575626 [TBL] [Abstract][Full Text] [Related]
7. Longitudinal Analysis of Tear Cytokine Ratios in Association with Dry Eye Signs and Symptoms in the Dry Eye Assessment and Management (DREAM) Study. Zhao CS; Chen Y; Yu Y; Ying GS; Asbell PA; Curr Eye Res; 2024 Sep; ():1-8. PubMed ID: 39267294 [TBL] [Abstract][Full Text] [Related]
8. Dry Eye Subtypes in the Dry Eye Assessment and Management (DREAM) Study: A Latent Profile Analysis. Yu K; Asbell PA; Shtein RM; Ying GS; Transl Vis Sci Technol; 2022 Nov; 11(11):13. PubMed ID: 36383391 [TBL] [Abstract][Full Text] [Related]
9. Dysregulated Tear Fluid Nociception-Associated Factors, Corneal Dendritic Cell Density, and Vitamin D Levels in Evaporative Dry Eye. Khamar P; Nair AP; Shetty R; Vaidya T; Subramani M; Ponnalagu M; Dhamodaran K; D'souza S; Ghosh A; Pahuja N; Deshmukh R; Ahuja P; Sainani K; Nuijts RMMA; Das D; Ghosh A; Sethu S Invest Ophthalmol Vis Sci; 2019 Jun; 60(7):2532-2542. PubMed ID: 31195410 [TBL] [Abstract][Full Text] [Related]
10. Study design and baseline findings from the progression of ocular findings (PROOF) natural history study of dry eye. McDonnell PJ; Pflugfelder SC; Stern ME; Hardten DR; Conway T; Villanueva L; Hollander DA BMC Ophthalmol; 2017 Dec; 17(1):265. PubMed ID: 29284427 [TBL] [Abstract][Full Text] [Related]
11. Systemic Conditions Associated with Severity of Dry Eye Signs and Symptoms in the Dry Eye Assessment and Management Study. Yu K; Bunya V; Maguire M; Asbell P; Ying GS; Ophthalmology; 2021 Oct; 128(10):1384-1392. PubMed ID: 33785415 [TBL] [Abstract][Full Text] [Related]
12. Effect of maqui-berry extract in dry eye disease - A clinical and molecular analysis. Kundu G; Shetty R; D'Souza S; Gorimanipalli B; Koul A; Sethu S Indian J Ophthalmol; 2023 Apr; 71(4):1613-1618. PubMed ID: 37026311 [TBL] [Abstract][Full Text] [Related]
13. Association Between Depression and Severity of Dry Eye Symptoms, Signs, and Inflammatory Markers in the DREAM Study. Zhou Y; Murrough J; Yu Y; Roy N; Sayegh R; Asbell P; Maguire MG; Ying GS; JAMA Ophthalmol; 2022 Apr; 140(4):392-399. PubMed ID: 35266971 [TBL] [Abstract][Full Text] [Related]
14. Association of Dry Eye Symptoms and Signs in Patients with Dry Eye Disease. Tawfik A; Pistilli M; Maguire MG; Chen Y; Yu Y; Greiner JV; Asbell PA; Ying GS; Ophthalmic Epidemiol; 2024 Jun; 31(3):274-282. PubMed ID: 37592829 [TBL] [Abstract][Full Text] [Related]
15. Response of tear cytokines following intense pulsed light combined with meibomian gland expression for treating meibomian gland dysfunction-related dry eye. Yu H; Zeng W; Zhao G; Hong J; Feng Y Front Endocrinol (Lausanne); 2022; 13():973962. PubMed ID: 36187125 [TBL] [Abstract][Full Text] [Related]
17. A distinct cytokines profile in tear film of dry eye disease (DED) patients with HIV infection. Agrawal R; Balne PK; Veerappan A; Au VB; Lee B; Loo E; Ghosh A; Tong L; Teoh SC; Connolly J; Tan P Cytokine; 2016 Dec; 88():77-84. PubMed ID: 27585367 [TBL] [Abstract][Full Text] [Related]
18. Influence of video display terminal use and meibomian gland dysfunction on the ocular surface and tear neuromediators. Bilgic AA; Kocabeyoglu S; Dikmetas O; Tan C; Karakaya J; Irkec M Int Ophthalmol; 2023 May; 43(5):1537-1544. PubMed ID: 36239837 [TBL] [Abstract][Full Text] [Related]
19. Correlations between tear cytokines, chemokines, and soluble receptors and clinical severity of dry eye disease. Na KS; Mok JW; Kim JY; Rho CR; Joo CK Invest Ophthalmol Vis Sci; 2012 Aug; 53(9):5443-50. PubMed ID: 22789923 [TBL] [Abstract][Full Text] [Related]
20. Biomarkers of ocular allergy and dry eye disease. Zemba M; Ionescu MA; Pîrvulescu RA; Dumitrescu OM; Daniel-Constantin B; Radu M; Stamate AC; Istrate S Rom J Ophthalmol; 2023; 67(3):250-259. PubMed ID: 37876509 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]